A detailed history of Sg Americas Securities, LLC transactions in Organon & Co. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 22,689 shares of OGN stock, worth $330,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,689
Previous 8,689 161.12%
Holding current value
$330,805
Previous $180,000 141.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$18.65 - $23.03 $261,099 - $322,420
14,000 Added 161.12%
22,689 $434,000
Q2 2024

Jul 12, 2024

BUY
$17.45 - $21.96 $151,623 - $190,810
8,689 New
8,689 $180,000
Q4 2023

Jan 12, 2024

BUY
$10.95 - $17.32 $477,562 - $755,377
43,613 Added 258.05%
60,514 $873,000
Q3 2023

Oct 13, 2023

SELL
$16.59 - $23.77 $885,706 - $1.27 Million
-53,388 Reduced 75.95%
16,901 $293,000
Q2 2023

Jul 10, 2023

BUY
$19.27 - $24.63 $1.08 Million - $1.38 Million
56,150 Added 397.13%
70,289 $1.46 Million
Q1 2023

Apr 28, 2023

BUY
$21.42 - $32.08 $126,549 - $189,528
5,908 Added 71.78%
14,139 $333,000
Q4 2022

Feb 02, 2023

SELL
$23.31 - $28.61 $124,825 - $153,206
-5,355 Reduced 39.42%
8,231 $230,000
Q3 2022

Oct 31, 2022

BUY
$23.4 - $34.25 $145,267 - $212,624
6,208 Added 84.14%
13,586 $318,000
Q2 2022

Jul 29, 2022

SELL
$31.66 - $38.9 $966,421 - $1.19 Million
-30,525 Reduced 80.53%
7,378 $249,000
Q1 2022

Apr 29, 2022

BUY
$30.45 - $39.36 $1.15 Million - $1.49 Million
37,903 New
37,903 $1.32 Million
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $253,098 - $327,783
-8,828 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$28.63 - $35.64 $2.63 Million - $3.28 Million
-91,970 Reduced 91.24%
8,828 $289,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $2.87 Million - $3.83 Million
100,798 New
100,798 $3.05 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.